BIOMARKERS FOR EARLY DETECTION OF DIABETIC NEPHROPATHY
DOI:
https://doi.org/10.15547/tjs.2025.02.012Keywords:
diabetes mellitus, diabetic nephropathy, microalbuminuriaAbstract
Diabetic nephropathy (DN) is the most common complication of type 2 diabetes mellitus and is the leading cause of end-stage renal disease worldwide. Early detection of diabetic nephropathy (DN) is critical because timely intervention can help slow the loss of kidney function and mitigate negative outcomes. It is crucial to diagnose patients at an early stage of DN, which is reversible and with the possibility of better control of the progression of the complication. As an early marker of DN, microalbuminuria is used in routine practice for screening and onset of the complication. On the other hand, kidney damage can occur even without microalbuminuria. There are several significant biomarkers of kidney damage in diabetes that allow detection of diabetic nephropathy at an early stage. This is crucial for timely treatment that can delay the development of DN and its progression. Therefore, this review focuses on laboratory biomarkers that are early, specific and that could potentially enable early diagnosis, treatment and delay of progression of diabetic nephropathy.
References
Dilworth, L., Facey, A., Omoruyi, F. Diabetes mellitus and its metabolic complications: the role of adipose tissues. Intern J Mol Sci, 22(14): 7644, 2021.
Hoogeveen, E. K. The epidemiology of diabetic kidney disease. Kidney and Dialysis, 2(3): 433-442, 2022.
Trifonova, O.P., Maslov, D.L., Balashova, E.E., Lichtenberg, S., Lokhov, P.G. Potential plasma metabolite biomarkers of diabetic nephropathy: untargeted metabolomics study. J Person Med, 12(11):1889, 2022.
Piwkowska, A., Zdrojewski, Ł., Heleniak, Z., Dębska-Ślizień, A. Novel markers in diabetic kidney disease—current state and perspectives. Diagnostics, 12(5):1205, 2022.
Pafundi, P. C., Garofalo, C., Galiero, R., Borrelli, S., Caturano, A., Rinaldi, L., Provenzano, M., Salvatore, T., De Nicola, L., Minutolo, R., & Sasso, F. C. Role of albuminuria in detecting cardio-renal risk and outcome in diabetic subjects. Diagnostics, 11(2): 290, 2021.
Xiao ,Z., Huang, Q., Yang, Y., Liu, M., Chen, Q., Huang, J., Xiang, Y., Long, X., Zhao, T., Wang, X., Zhu, X., Tu, S., Ai, K. Emerging early diagnostic methods for acute kidney injury. Theranostics. 21, 12(6):2963-2986, 2022
Haines, R. W., Fowler, A. J., Liang, K., Pearse, R. M., Larsson, A. O., Puthucheary, Z., and Prowle, J. R. Comparison of cystatin C and creatinine in the assessment of measured kidney function during critical illness. Clin J Am Soc Nephrol, 18(8): 997-1005, 2023.
Benoit, S.W., Ciccia, E.A., Devarajan, P. Cystatin C as a biomarker of chronic kidney disease: latest developments. Expert Rev Mol Diagn. 20(10):1019-1026, 2020
Gembillo, G., Ingrasciotta, Y., Crisafulli, S., Luxi, N., Siligato, R., Santoro, D., Trifirò, G. Kidney disease in diabetic patients: from pathophysiology to pharmacological aspects with a focus on therapeutic inertia. Intern J Mol Sci, 22(9): 4824, 2021.
Jaques, D.A., Spahr, L., Berra, G., Poffet, V., Lescuyer, P., Gerstel, E., ... and Ponte, B. Biomarkers for acute kidney injury in decompensated cirrhosis: a prospective study. Nephrol, 24(2): 170-180, 2019.
Yasuda, K., Nakanishi, K., and Tsutsui, H. Interleukin-18 in health and disease. Internat j mol sci, 20(3), 649, 2019.
Naber, T., and Purohit, S. Chronic kidney disease: role of diet for a reduction in the severity of the disease. Nutrients, 13(9): 3277, 2021.
Argyropoulos, C.P., Chen, S.S., Ng, Y.H., Roumelioti, M.E., Shaffi, K., Singh, P.P., Tzamaloukas, A.H. Rediscovering Beta-2 microglobulin as a biomarker across the spectrum of kidney diseases. Front Med (Lausanne). 15(4):73, 2017.
Panayotova, M. Oxidative stress and inflammatory bowel disease in pediatrics. Trakia J Sci, 21(4): 375, 2023.
Iłżecka, J., Iłżecki, M., Grabarska, A., Dave, S., Feldo, M., and Zubilewicz, T. Clusterin as a potential marker of brain ischemia-reperfusion injury in patients undergoing carotid endarterectomy. Upsala J Med Sci, 124(3): 193-198, 2019.
Gheith, O., Farouk, N., Nampoory, N., Halim, M. A., and Al-Otaibi, T. Diabetic kidney disease: worldwide difference of prevalence and risk factors. J Nephropharm, 5(1): 49, 2015.
Panayotova, M., Penkova, M. Measurement of oxidative stress-related markers in gastro-intestinal damages in Bulgarian pediatric patients. Bulg Chem Commun, 56(SI):142-147, 2024
Gburek, J., Konopska, B., and Gołąb, K. Renal handling of albumin—from early findings to current concepts. Internat J Mol Sci, 22(11): 5809, 2021.
Anders, H.J., Huber, T.B., Isermann, B., and Schiffer, M. CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease. Nat Rev Nephrol, 14(6): 361-377, 2018.
Cole, J. B., Florez, J. C. Genetics of diabetes mellitus and diabetes complications. Nature reviews nephrology, 16(7): 377-390, 2020.
Giacco, F., Brownlee, M. Oxidative stress and diabetic complications. Circulat res, 107 (9): 1058–1070, 2010.
Mengozzi, A., Pugliese, N. R., Chiriaco, M., Masi, S., Virdis, A., and Taddei, S. Microvascular ageing links metabolic disease to age-related disorders: the role of oxidative stress and inflammation in promoting microvascular dysfunction. J Cardiovasc Pharmacol, 78: S78-S87, 2021.
Koulis, C., Watson, A. M. D., Gray, S. P., and Jandeleit-Dahm, K. A. Linking RAGE and Nox in diabetic micro-and macrovascular complications. Diabetes & metabolism, 41(4): 272-281, 2015.
Mangana, C., Lorigo, M., & Cairrao, E. Implications of endothelial cell-mediated dysfunctions in vasomotor tone regulation. Biologics, 1(2), 231-251, 2021.
Kolluru, G. K., Bir, S.C., Kevil, C.G. Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Intern J Vasc Med, 2012(1): 918267, 2012
Sifuentes-Franco, S., Padilla-Tejeda, D. E., Carrillo-Ibarra, S., Miranda-Díaz, A.G. Oxidative stress, apoptosis, and mitochondrial function in diabetic nephropathy. Intern J Endocrinol, 2018(1): 1875870, 2018.
Twarda-Clapa, A., Olczak, A., Białkowska, A. M., Koziołkiewicz, M. Advanced glycation end-products (AGEs): Formation, chemistry, classification, receptors, and diseases related to AGEs. Cells, 11(8): 1312, 2022.
Förstermann, U., & Sessa, W.C. Nitric oxide synthases: regulation and function. Europ Heart J, 33(7): 829-837, 2012.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
